PTPRT and breast carcinoma: Based on TCGA data, PTPRT was higher in pT1 breast cancer patients (RNA-Seq by Expectation-Maximization (RSEM), log2, median 9.46, IQR 6.42-11.02) than those in pT2 (median 8.41, IQR 5.40-10.60) and pT4 (median 7.45, IQR 5.18-9.85), and similar to that in pT3 breast cancer patients (median 8.92, IQR 5.58-10.46).